Oncology Pharma (ONPH) Short Interest Ratio & Short Volume $0.0002 +0.00 (+100.00%) As of 01:51 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort InterestBuy This Stock Oncology Pharma Short Interest DataOncology Pharma (ONPH) has a short interest of 13,500 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 3.2, indicating that it would take 3.2 days of the average trading volume of 3,126 shares to cover all short positions.Current Short Interest13,500 sharesPrevious Short Interest13,500 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$1.35Short Interest Ratio3.2 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares38,663,000 sharesPercentage of Shares Shorted0.03%Today's Trading Volume1,534 sharesAverage Trading Volume3,126 sharesToday's Volume Vs. Average49% Short Selling Oncology Pharma? Sign up to receive the latest short interest report for Oncology Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartONPH Short Interest Over TimeONPH Days to Cover Over TimeONPH Percentage of Float Shorted Over Time Oncology Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202513,500 shares $1.35 No ChangeN/A3.2 $0.00 6/30/202513,500 shares $0.00 No Change0.0%6.8 $0.00 6/15/202513,500 shares $1.35 No Change0.0%6.4 $0.00 5/31/202513,500 shares $1.35 No ChangeN/A3.2 $0.00 5/15/202513,500 shares $1.35 No ChangeN/A4 $0.00 4/30/202513,500 shares $1.35 No ChangeN/A3.6 $0.00 4/15/202513,500 shares $1.35 No ChangeN/A0.5 $0.00 3/31/202513,500 shares $0.00 No ChangeN/A2 $0.00 3/15/202513,500 shares $1.35 No ChangeN/A0.6 $0.00 2/28/202513,500 shares $0.00 No ChangeN/A2.5 $0.00 Get the Latest News and Ratings for ONPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncology Pharma and its competitors with MarketBeat's FREE daily newsletter. 2/15/202513,500 shares $0.00 No ChangeN/A22.5 $0.00 1/31/202513,500 shares $0.00 No ChangeN/A3.6 $0.00 1/15/202513,500 shares $1.35 No ChangeN/A3.1 $0.00 12/31/202413,500 shares $1.35 No ChangeN/A0.3 $0.00 12/15/202413,500 shares $2.70 No ChangeN/A0.5 $0.00 11/30/202413,500 shares $0.00 No ChangeN/A0.6 $0.00 11/15/202413,500 shares $0.00 No ChangeN/A1.6 $0.00 10/31/202413,500 shares $0.00 No ChangeN/A4.1 $0.00 10/15/202413,500 shares $1.35 No ChangeN/A3.8 $0.00 9/30/202413,500 shares $0.00 No ChangeN/A1.1 $0.00 9/15/202413,500 shares $0.00 No ChangeN/A0.4 $0.00 8/31/202413,500 shares $0.00 No ChangeN/A0.5 $0.00 8/15/202413,500 shares $2.70 No ChangeN/A4.7 $0.00 7/31/202413,500 shares $2.70 No ChangeN/A9.6 $0.00 7/15/202413,500 shares $0.00 No ChangeN/A1.2 $0.00 6/30/202413,500 shares $0.00 No ChangeN/A4.8 $0.00 6/15/202413,500 shares $0.00 No ChangeN/A4.8 $0.00 5/31/202413,500 shares $0.00 -3.6%N/A2.7 $0.00 5/15/202414,000 shares $0.00 +3.7%N/A6.1 $0.00 4/30/202413,500 shares $0.00 No ChangeN/A1.5 $0.00 4/15/202413,500 shares $135.00 No ChangeN/A1.2 $0.01 3/31/202413,500 shares $1.35 No ChangeN/A4.5 $0.00 3/15/202413,500 shares $0.00 -0.7%N/A1.7 $0.00 2/29/202413,600 shares $0.00 No ChangeN/A2.4 $0.00 2/15/202413,600 shares $0.00 No ChangeN/A2.7 $0.00 1/15/202413,600 shares $0.00 No ChangeN/A3 $0.00 12/31/202313,600 shares $2.72 -4.9%N/A0.1 $0.00 12/15/202314,300 shares $2.86 -10.1%N/A0.3 $0.00 11/30/202315,900 shares $15.90 -52.0%N/A1 $0.00 11/15/202333,100 shares $33.10 -32.2%N/A2.7 $0.00The Tiny Stock Set to Soar with Musk's AI Ambitions (Ad)The Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires in history, one tiny AI stock is flying under the radar. While you can't invest directly, we've pinpointed a stock poised to benefit immensely from his plans.Discover our top AI stock pick for 2025 >>> 10/31/202348,800 shares $976.00 -17.2%N/A10 $0.02 10/15/202358,900 shares $2.21 thousand -35.5%N/A6.5 $0.04 9/30/202391,300 shares $5.93 thousand -1.0%N/A13.8 $0.07 9/15/202392,200 shares $4.38 thousand -1.4%N/A10.5 $0.05 8/31/202393,500 shares $2.34 thousand +523.3%N/A4.3 $0.03 8/15/202315,000 shares $4.28 thousand -6.8%N/A0.2 $0.29 7/31/202316,100 shares $5.73 thousand +16.7%N/A0.3 $0.36 7/15/202313,800 shares $5.42 thousand -21.1%N/A0.3 $0.39 6/30/202317,500 shares $5.60 thousand +19.9%N/A0.1 $0.32 6/15/202314,600 shares $8.18 thousand -3.3%N/A0 $0.56 5/31/202315,100 shares $2.11 thousand -22.6%N/A0.1 $0.14 5/15/202319,500 shares $2.73 thousand +20.4%N/A0.1 $0.14 4/30/202316,200 shares $2.59 thousand -30.5%N/A0.1 $0.16 4/15/202323,300 shares $3.90 thousand -14.7%N/A0.2 $0.17 3/31/202327,300 shares $5.05 thousand +45.2%N/A0.1 $0.19 3/15/202318,800 shares $5.45 thousand -25.1%N/A0.2 $0.29 2/28/202325,100 shares $9.09 thousand +9.6%N/A0.4 $0.36 2/15/202322,900 shares $8.70 thousand -24.7%N/A0.2 $0.38 1/31/202330,400 shares $11.70 thousand +28.8%N/A0.3 $0.39 1/15/202323,600 shares $9.68 thousand -32.2%N/A0.1 $0.41 12/30/202234,800 shares $11.78 thousand +5.1%N/A0.1 $0.34 12/15/202233,100 shares $16.88 thousand -3.2%N/A0.2 $0.51 11/30/202234,200 shares $24.54 thousand -6.8%N/A0.6 $0.72 11/15/202236,700 shares $34.13 thousand -35.8%N/A0.2 $0.93 10/31/202257,200 shares $50.85 thousand -5.9%N/A0.5 $0.89 10/15/202260,800 shares $26.14 thousand -60.2%N/A0.4 $0.43 9/30/2022152,700 shares $70.24 thousand +2.9%N/A1 $0.46 9/15/2022148,400 shares $129.09 thousand +1.0%N/A2.5 $0.87 8/31/2022146,900 shares $149.84 thousand -0.2%N/A1.6 $1.02 8/15/2022147,200 shares $198.72 thousand -14.6%N/A1.3 $1.35 7/31/2022172,400 shares $231.02 thousand -6.7%N/A1.1 $1.34 7/15/2022184,700 shares $265.97 thousand -33.3%N/A1.2 $1.44 6/30/2022276,800 shares $405.79 thousand -4.2%N/A3.7 $1.47 6/15/2022288,900 shares $433.35 thousand -28.2%N/A1.8 $1.50 5/31/2022402,600 shares $805.20 thousand -3.3%N/A4.3 $2.00 5/15/2022416,300 shares $865.28 thousand -3.8%N/A2.8 $2.08 4/30/2022432,500 shares $1.28 million -1.0%N/A4.2 $2.96 4/15/2022437,000 shares $1.56 million +1.8%N/A4.2 $3.57 3/31/2022429,400 shares $1.59 million -16.6%N/A3 $3.70 3/15/2022515,000 shares $2.11 million -4.8%N/A1.6 $4.10 2/28/2022541,000 shares $2.75 million -4.0%N/A1 $5.08 2/15/2022563,400 shares $3.61 million +41.1%N/A1.2 $6.41 1/31/2022399,400 shares $1.34 million +4.0%N/A3.4 $3.36 1/15/2022384,100 shares $1.43 million -9.3%N/A1.4 $3.72 12/31/2021423,300 shares $1.71 million +5.4%N/A0.8 $4.05 12/15/2021401,700 shares $1.27 million +25.2%N/A0.8 $3.15 11/30/2021320,800 shares $1.75 million +4.8%N/A0.9 $5.44 11/15/2021306,200 shares $2.50 million -18.1%N/A0.4 $8.15 10/29/2021373,800 shares $4.68 million -9.8%N/A0.4 $12.52 10/15/2021414,600 shares $5.78 million +37.7%N/A0.5 $13.95The Tiny Stock Set to Soar with Musk's AI Ambitions (Ad)The Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires in history, one tiny AI stock is flying under the radar. While you can't invest directly, we've pinpointed a stock poised to benefit immensely from his plans.Discover our top AI stock pick for 2025 >>> 9/30/2021301,200 shares $3.26 million +78.0%N/A0.7 $10.82 9/15/2021169,200 shares $2.29 million +3.2%N/A0.4 $13.53 8/31/2021164,000 shares $3.15 million +98.6%N/A0.4 $19.20 8/13/202182,600 shares $1.68 million +32.2%N/A0.2 $20.30 7/30/202162,500 shares $1.39 million +79.1%N/A0.1 $22.17 7/15/202134,900 shares $731.16 thousand +160.5%N/A0.1 $20.95 6/30/202113,400 shares $0.00 -82.2%N/A0 $0.00 ONPH Short Interest - Frequently Asked Questions What is Oncology Pharma's current short interest? Short interest is the volume of Oncology Pharma shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 13,500 shares of ONPH short. Learn More on Oncology Pharma's current short interest. What is a good short interest ratio for Oncology Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ONPH shares currently have a short interest ratio of 3.0. Learn More on Oncology Pharma's short interest ratio. How does Oncology Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "computer software" compare to Oncology Pharma: LZG International, Inc. (0.00%), Presto Automation Inc. (0.00%), Grom Social Enterprises, Inc. (0.00%), Kubient, Inc. (0.01%), Beamr Imaging Ltd. (3.09%), and Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Oncology Pharma stock? Short selling ONPH is an investing strategy that aims to generate trading profit from Oncology Pharma as its price is falling. ONPH shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Oncology Pharma? A short squeeze for Oncology Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ONPH, which in turn drives the price of the stock up even further. How often is Oncology Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ONPH, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies LZG International Short Squeeze Presto Automation Short Squeeze Grom Social Enterprises Short Squeeze Kubient Short Squeeze American Green Short Squeeze AppTech Payments Short Squeeze Arbe Robotics Short Squeeze Arogo Capital Acquisition Short Squeeze Artificial Intelligence Technology Solutions Short Squeeze Aurora Innovation Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ONPH) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredElon Musk: “Nothing happens without this…”Lithium has fueled the EV boom, but another resource is even more critical. Without it, over 20 million electr...Behind the Markets | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncology Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access